Shire PLC
|
Hampshire International Business Pk
Chineham, Basingstoke
Hampshire RG24 8EP
United Kingdom |
| Tel: |
44/1264/333455 |
| URL: |
http://www.shire.com |
|
| Formerly known as: |
| Shire Ltd |
| Shire PLC |
 |
| Primary Symbol & Exchange: |
| SHP - Ordinary Shares - London |
| Other Symbol & Exchange: |
| SHPGY - ADR - NASDAQ |
|
|
| Industry: |
| Pharmaceutical |
|
|
|
|
|
|
|
| Mergers & Acquisitions: |
| Shire PLC Mergers and Acquisitions
|
|
Thomson Financial Business Description:
| The Group's principal activity is researching, developing and marketing prescription medicines. It focuses on therapeutic areas namely, Attention-Deficit Hyperactivity Disorder, gastrointestinal, human genetic therapies and renal. The Group operates in two segments; Specialty Pharmaceuticals and Human Genetic Therapies (HGT). It products trademarks include Adderall XR, Adderall, Calcichew, Carbatrol, Daytrana, Elaprase, Fosrenol, Intuniv, Lialda, Mezavant,Reminyl, Reminyl XL, Replagal, Vyvanse and Xagrid. The Group operates in the United Kingdom, the United States of America, the Netherlands, France, Germany, Italy, Spain, Ireland, Canada and Sweden. |
|
Alacra Alerts:
 
|
Receive alerts on the latest reports on Shire PLC
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
|
|
